BioIonix, Inc. is a Madison, Wisconsin area company formed to commercialize proprietary patents, trade secrets and knowhow for a breakthrough process that disinfects and oxidizes a wide variety of liquid streams.  The process does this with extremely low operating costs and a quick payback of investment for many applications.   

The company’s process, trade named BioIonix™,  is a broadly enabling one that is being developed into a modular product line with applications across a number of different industries.  These include water and wastewater treatment, pulp and paper brightening, food processing, and environmental remediation.  The technology lies at the intersection between the biological and the physical sciences, where some of the most commercially useful discoveries are expected to be made over the next decade.

Board of Directors

The BioIonix board of directors consists of five members, including three outside directors.

James A. Tretheway, BSME, MBA.  Founder, President and CEO. 

Mr. Tretheway is a company founder and leads the company as president and CEO.  He is a seasoned business executive with a strong background in early-stage, high-technology businesses.  As general manager for an early-stage medical device company, Orascoptic Research, Inc., he grew the company from a negative net worth to high sales growth and profitability, leading to a sale to a private investment group.  He has many years of experience in similar roles in high-technology companies both here and overseas.  In his role as a licensing manager at the Wisconsin Alumni Research Foundation, Mr. Tretheway developed intellectual property commercialization strategies and assisted high-tech faculty startup companies. Mr. Tretheway as a BS in mechanical engineering and an MBA.

Kenneth J. Schlager, Ph.D.  Founder, VP of Research. 

Dr. Schlager is the primary inventor of the company’s technology and has over 30 years experience in designing cutting-edge electrical engineering products.  He has led the development of high tech products for a number of companies, including an successful startup company that serves the water/wastewater instrumentation market.  Currently Dr. Schlager works for BioIonix on a part-time consulting basis focused on developing the company’s next-generation system.  He also is transferring his know-how and trade secrets relating to his six years of development work on the BioIonix process to the company's internal engineering team. Dr. Schlager has a PhD in Electrical Engineering, an MS in Industrial Management, and is a registered professional engineer. 

T. Rockwell Mackie, Ph.D.  Outside director and investor. 

Dr. Mackie is founder and chairman of the board of Tomotherapy, Inc.  Over a period of ten years Tomotherapy has grown from a startup to a rapidly-growing and profitable maker of advanced radiation therapy equipment with over 500 employees.  Tomotherapy is now a public company with a valuation in excess of one billion dollars.  Prior to Tomotherapy, Dr. Mackie was a founder of a medical software company, Geometrics, that has been sold and is now part of Royal Philips, N.V.  Dr. Mackie also is a professor of medical physics at the University of Wisconsin – Madison and holds dozens of patents worldwide.  His work with electromagnetic fields has many commonalities with the technology BioIonix is commercializing.  Dr. Mackie brings strong business and technical expertise to the board.  He invested in BioIonix in the most recent funding round.

Ronald L. Bond.  Outside director. 

Mr. Bond is president and CEO of Marshall Bond Pumps, Inc.  This company is a supplier of capital equipment to the water and wastewater industries.  He brings extensive industry experience and knowledge of market opportunities, industry contacts and potential customers.  Mr. Bond provides strong input on customer needs and process applications, as well as important direction to the company’s laboratory development work and interpretation of results.  He offers particular expertise in evaluating competitive technologies and the customer benefits associated with the BioIonix process.    

Mark T. Nelson, MBA.  Outside director and investor. 

Mr. Nelson was an owner and senior executive of Nelson-Jameson, Inc.  This company is a respected supplier of products used by the food, dairy and beverage processing industries.  Mr. Nelson brings extensive business experience and knowledge of market needs in a number of the industries that BioIonix expects to serve.  BioIonix particularly benefits from his expertise in marketing and sales through distributors and independent representatives.  Mr. Nelson invested in BioIonix both at an early stage and in the most recent funding round.  He is also a member of a regional investment group whose members are major shareholders of BioIonix.

Home | About Us | Products | Applications | News | Investors | Careers | Contact Us

BioIonix, Inc. ▪ 4603 Triangle Street, McFarland, Wisconsin 53558 ▪ 608-838-0300 ▪ www.bioionix.com